Pangaea Oncology Company Description

Pangaea Oncology, S.A., a precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

The company offers molecular diagnostics, including mutation analysis in tissue and liquid biopsy; gene amplification and translocation testing; immunohistochemistry (IHC) and fluorescence in-situ hybridization (FISH); gene expression profiling and transcriptomic signatures; and tumor mutational burden (TMB) and microsatellite instability and (MSI) assessment services.

It also provides diagnostic platforms validation and pre-clinical services. Pangaea Oncology, S.A. was incorporated in 2006 and is based in Zaragoza, Spain.

Pangaea Oncology, S.A.

Country	Spain
Founded	2006
Industry	Diagnostics & Research
Sector	Healthcare
Employees	165
CEO	Javier Rivela-Rodriguez

Contact Details

Address: Calle Coso nº 55, 3º Zaragoza Spain
Phone	34 93 409 79 81
Website	panoncology.com

Stock Details

Ticker Symbol	PANG
Exchange	Madrid Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	ES0105221008
SIC Code	2836

Key Executives

Name	Position
Javier Rivela-Rodriguez C.F.A., M.B.A.	Co-Founder, Chief Executive Officer and Director
Dr. Rafael Rosell Costa M.D., Ph.D.	Chief Scientific Officer, Director, President and Member of Scientific Committee
Alejandro Garcia Moncayo M.B.A.	Executive Director of Corporate and Chief Financial Officer
Carmen Albiol	Head of Operations for IOR
Dr. Miguel Angel Molina B.Sc., Ph.D.	Executive Director of Research and Development and Member of Scientific Committee
Alejandro Martinez M.D.	Chief Medical Officer and Medical Director at IOR (Hospital Universitari Dexeus)
Cristina Masferrer EMBA	Chief Business Officer